• No se han encontrado resultados

TítuloLiver toxicity and risk of discontinuation in HIV/hepatitis C virus coinfected patients receiving an etravirine containing antiretroviral regimen: influence of liver fibrosis

N/A
N/A
Protected

Academic year: 2020

Share "TítuloLiver toxicity and risk of discontinuation in HIV/hepatitis C virus coinfected patients receiving an etravirine containing antiretroviral regimen: influence of liver fibrosis"

Copied!
8
0
0

Texto completo

Loading

Figure

Table 1. Baseline characteristics of patients according to HIV/hepatitis C virus (HCV) coinfection  Variable  Overall  (n = 211)  HIV/HCV coinfection (n = 145; 69%)  HIV monoinfected (n = 66; 31%)  P-value
Figure 1. Changes in alanine aminotransferase (ALT) concentration during the first year after etravirine  initiation (at baseline and months 3, 6 and 12), according to (a) hepatitis C virus (HCV) serostatus and (b)  the degree of liver fibrosis

Referencias

Documento similar

In this study, internal tissues of chicken liver samples were analysed for the presence of phages using a meta- genomics approach and the liver virome was compared with that of

In our study, admitted COVID-19 patients with CLD and abnormal admission LFTs had higher median levels of D-dimer, which could be associated with major systemic inflammation and

We aimed to detect the most relevant changes in peripheral immune biomarkers among HIV/HCV-coinfected patients who achieved sustained virologic response (SVR)

Of special concern for this work are outbreaks formed by the benthic dinoflagellate Ostreopsis (Schmidt), including several species producers of palytoxin (PLTX)-like compounds,

Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver in patients undergoing hematopoietic stem cell transplantation. Plasminogen activator inhibitor-1

Integrated HIV DNA was quantified by q-PCR in cross- sectional samples from different groups of patients: (1) HIV+ group: HIV-monoinfected patients that had never been in contact

This analysis showed that levels of both exhaustion and activation of effector CD4 T-cells were significantly increased in pre-DAAs HIV/HCV patients compared to HIV patients,

Subjects with liver cirrhosis, parenteral drug users, cases of prosthetic endocarditis, and patients who did not undergo surgical treatment had an increased risk of a second IE